Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19
Author(s) -
Emmanuel Lafont,
Hélène Péré,
David Lebeaux,
Geoffrey Cheminet,
Éric Thervet,
R. Guillemain,
Adrien Flahault
Publication year - 2022
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac253
Subject(s) - covid-19 , virology , betacoronavirus , medicine , sars virus , pandemic , pneumonia , coronavirus infections , infectious disease (medical specialty) , outbreak , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom